Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Carotid artery dissection (CAD) is a recognized cause of ischemic stroke (IS) in young adults. At the same time, hyperthyroidism, particularly in the context of thyroid storm (TS), can also lead to IS through mechanisms related and unrelated to atrial fibrillation (AF). However, the coexistence of CAD and thyrotoxicosis is extremely rare. We report the case of a 45-year-old woman with Graves' disease (GD) who presented with TS, developing IS secondary to left CAD. The patient had a history of poorly controlled hyperthyroidism despite being on methimazole and beta-blocker therapy. Upon admission, she presented with fever, diarrhea, tremor, and palpitations. Physical examination revealed bilateral exophthalmos, goiter, and AF. Thyroid function tests confirmed TS, and treatment was initiated with antithyroid drugs, beta-blockers, glucocorticoids, and plasma exchange. Three days later, she developed focal neurological symptoms, and imaging studies revealed multiple ischemic lesions in the left middle cerebral artery territory. Further investigation confirmed left internal CAD, with no evidence of trauma or other underlying conditions to explain the dissection, leading to the conclusion that GD was the likely cause. The patient underwent thyroidectomy with subsequent clinical improvement, and she was discharged in good condition with long-term anticoagulation due to the presence of AF. This case highlights a rare association between GD and CAD, emphasizing the importance of considering CAD in patients with thyrotoxicosis who present with unexplained focal neurological symptoms. Early recognition and management of TS and CAD can improve clinical outcomes.
Carotid artery dissection (CAD) is a recognized cause of ischemic stroke (IS) in young adults. At the same time, hyperthyroidism, particularly in the context of thyroid storm (TS), can also lead to IS through mechanisms related and unrelated to atrial fibrillation (AF). However, the coexistence of CAD and thyrotoxicosis is extremely rare. We report the case of a 45-year-old woman with Graves' disease (GD) who presented with TS, developing IS secondary to left CAD. The patient had a history of poorly controlled hyperthyroidism despite being on methimazole and beta-blocker therapy. Upon admission, she presented with fever, diarrhea, tremor, and palpitations. Physical examination revealed bilateral exophthalmos, goiter, and AF. Thyroid function tests confirmed TS, and treatment was initiated with antithyroid drugs, beta-blockers, glucocorticoids, and plasma exchange. Three days later, she developed focal neurological symptoms, and imaging studies revealed multiple ischemic lesions in the left middle cerebral artery territory. Further investigation confirmed left internal CAD, with no evidence of trauma or other underlying conditions to explain the dissection, leading to the conclusion that GD was the likely cause. The patient underwent thyroidectomy with subsequent clinical improvement, and she was discharged in good condition with long-term anticoagulation due to the presence of AF. This case highlights a rare association between GD and CAD, emphasizing the importance of considering CAD in patients with thyrotoxicosis who present with unexplained focal neurological symptoms. Early recognition and management of TS and CAD can improve clinical outcomes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.